On Oct. 9, the Senate, by a voice vote, adopted an amendment to the National Defense Authorization Act (NDAA) from Sens. Bill Hagerty (R-TN) and Gary Peters (D-MI), which adds an updated version of ...

The majority of the bill has remained unchanged from the 2024 version passed by the House of Representatives, which included the following features described in our September 2024 Alert: By not ...

Debut Biotech, a company innovating new molecules through advanced biotechnology, is partnering with Image Skincare to launch ...

Still, the recently released 2025-30 Arizona Bioscience Roadmap, as well as several academic, community and local government ...

US biotech Moderna (Nasdaq: MRNA) is discontinuing its once-promising vaccine for congenital cytomegalovirus (CMV) after the shot failed to prevent primary infection in healthy women during a Phase ...

Explore the unique issues of rare disease trials and how “gene silencing” therapies could reshape the future for patients ...

Latin America faces a productivity crisis as industry declines and exports revert to raw materials, according to new ECLAC ...

Nowadays, you can find entire aisles of beauty products in any drugstore, including lotions that promise youth in a bottle, ...

This was a new position; the IBB stake now accounts for 8.7% of Florin Court Capital LLP’s 13F AUM Top five holdings after ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

SOUTH SAN FRANCISCO, Calif., November 03, 2025--(BUSINESS WIRE)--Star Therapeutics, a clinical stage biotechnology company ...